Literature DB >> 30353339

Neuroprotective Lithium Salts Protect Pancreatic β-Сells from Damage.

R U Ostrovskaya1, S V Ivanov2, A D Durnev2.   

Abstract

We studied antidiabetic effects and cytoprotective activity of two lithium salts (lithium chloride and lithium carbonate) on the model of streptozotocin-induced diabetes mellitus type 2 in Wistar rats. Using the method of β-cells detection with antibodies to insulin, we demonstrated that streptozotocin reduced the number of β-cells and impaired their morphological structure. Both lithium preparations administered to diabetic animals for 28 days in doses of 10 and 8.9 mg/kg, respectively, attenuated the damaging effect of streptozotocin. This cytoprotective effect of lithium salts manifested in weakening of hyperglycemia, polyphagia, polydipsia, and weight loss. A satisfactory correlation between the morphometric data and blood glucose levels was revealed. The mechanisms of the multitarget action of lithium salts are discussed.

Entities:  

Keywords:  diabetes mellitus 2 type; lithium salts; streptozotocin; β-cells, cytoprotection

Mesh:

Substances:

Year:  2018        PMID: 30353339     DOI: 10.1007/s10517-018-4259-7

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  1 in total

1.  Microdose Lithium Protects against Pancreatic Islet Destruction and Renal Impairment in Streptozotocin-Elicited Diabetes.

Authors:  Jiahui Zhang; Fnu Anshul; Deepak K Malhotra; Juan Jaume; Lance D Dworkin; Rujun Gong
Journal:  Antioxidants (Basel)       Date:  2021-01-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.